Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sepsis | 38 | 2020 | 145 | 8.480 |
Why?
|
Inflammation | 25 | 2019 | 501 | 5.000 |
Why?
|
Sirtuin 1 | 13 | 2020 | 36 | 4.150 |
Why?
|
Monocytes | 15 | 2019 | 119 | 3.400 |
Why?
|
Endotoxins | 14 | 2016 | 36 | 3.190 |
Why?
|
Immune Tolerance | 16 | 2019 | 67 | 3.150 |
Why?
|
Epigenesis, Genetic | 10 | 2019 | 98 | 2.990 |
Why?
|
Lipopolysaccharides | 19 | 2019 | 104 | 2.540 |
Why?
|
Gene Silencing | 8 | 2011 | 50 | 2.500 |
Why?
|
Tumor Necrosis Factor-alpha | 15 | 2018 | 203 | 2.450 |
Why?
|
Immunity, Innate | 7 | 2019 | 64 | 2.370 |
Why?
|
Lung Injury | 8 | 2018 | 64 | 2.240 |
Why?
|
Transcription Factor RelB | 11 | 2014 | 25 | 2.170 |
Why?
|
Energy Metabolism | 7 | 2019 | 139 | 2.120 |
Why?
|
Gene Expression Regulation | 16 | 2017 | 467 | 2.100 |
Why?
|
Sirtuins | 5 | 2018 | 19 | 1.940 |
Why?
|
Contusions | 7 | 2018 | 41 | 1.880 |
Why?
|
MicroRNAs | 12 | 2019 | 170 | 1.870 |
Why?
|
Mice | 36 | 2020 | 2181 | 1.750 |
Why?
|
Transcription, Genetic | 8 | 2011 | 138 | 1.610 |
Why?
|
Animals | 47 | 2020 | 6402 | 1.560 |
Why?
|
Myeloid Cells | 9 | 2019 | 35 | 1.400 |
Why?
|
Leukocytes | 10 | 2017 | 52 | 1.370 |
Why?
|
Promoter Regions, Genetic | 10 | 2016 | 218 | 1.280 |
Why?
|
Histones | 9 | 2017 | 48 | 1.130 |
Why?
|
Mice, Inbred C57BL | 15 | 2020 | 619 | 1.110 |
Why?
|
Homeostasis | 6 | 2018 | 140 | 1.070 |
Why?
|
Toll-Like Receptor 4 | 9 | 2013 | 41 | 1.070 |
Why?
|
Disease Models, Animal | 20 | 2020 | 915 | 1.060 |
Why?
|
Heterochromatin | 5 | 2011 | 10 | 1.050 |
Why?
|
Glucose | 3 | 2018 | 163 | 1.010 |
Why?
|
Signal Transduction | 9 | 2019 | 607 | 0.880 |
Why?
|
Interleukin-6 | 9 | 2018 | 224 | 0.850 |
Why?
|
Cell Line | 14 | 2016 | 418 | 0.840 |
Why?
|
Humans | 49 | 2019 | 28304 | 0.840 |
Why?
|
Histocompatibility Antigens | 3 | 2009 | 10 | 0.800 |
Why?
|
Histone-Lysine N-Methyltransferase | 3 | 2009 | 21 | 0.790 |
Why?
|
Drug Resistance | 2 | 2011 | 34 | 0.750 |
Why?
|
Cell Nucleus | 3 | 2018 | 104 | 0.750 |
Why?
|
Interleukin-1beta | 5 | 2011 | 40 | 0.750 |
Why?
|
Oxidative Stress | 3 | 2019 | 249 | 0.750 |
Why?
|
Mitochondria | 3 | 2018 | 175 | 0.750 |
Why?
|
Cysteine | 2 | 2019 | 129 | 0.740 |
Why?
|
Adaptive Immunity | 2 | 2018 | 14 | 0.700 |
Why?
|
Pyruvate Dehydrogenase Complex | 1 | 2018 | 13 | 0.670 |
Why?
|
Protein Biosynthesis | 6 | 2015 | 42 | 0.660 |
Why?
|
Macrophages | 6 | 2017 | 183 | 0.630 |
Why?
|
Antioxidants | 1 | 2018 | 117 | 0.630 |
Why?
|
NFI Transcription Factors | 5 | 2017 | 13 | 0.620 |
Why?
|
Lung | 5 | 2018 | 232 | 0.620 |
Why?
|
Chemokine CXCL1 | 5 | 2012 | 16 | 0.600 |
Why?
|
Mice, Knockout | 12 | 2019 | 392 | 0.590 |
Why?
|
DNA Methylation | 7 | 2017 | 125 | 0.580 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 4 | 0.570 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2016 | 4 | 0.570 |
Why?
|
Immunity | 2 | 2017 | 16 | 0.540 |
Why?
|
RNA, Messenger | 7 | 2016 | 498 | 0.540 |
Why?
|
I-kappa B Proteins | 3 | 2011 | 11 | 0.530 |
Why?
|
Platelet Adhesiveness | 3 | 2015 | 13 | 0.530 |
Why?
|
Male | 31 | 2020 | 16967 | 0.530 |
Why?
|
Sirtuin 3 | 1 | 2014 | 3 | 0.520 |
Why?
|
Sirtuin 2 | 4 | 2019 | 10 | 0.520 |
Why?
|
Phenotype | 3 | 2017 | 653 | 0.510 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 4 | 2019 | 4 | 0.510 |
Why?
|
Complement Activation | 1 | 2014 | 10 | 0.490 |
Why?
|
Toll-Like Receptor 2 | 3 | 2012 | 13 | 0.480 |
Why?
|
Transcription Factor RelA | 7 | 2019 | 23 | 0.470 |
Why?
|
Alzheimer Disease | 1 | 2016 | 291 | 0.440 |
Why?
|
HMGB1 Protein | 2 | 2009 | 5 | 0.430 |
Why?
|
Glycolysis | 4 | 2018 | 19 | 0.420 |
Why?
|
Myelopoiesis | 1 | 2011 | 2 | 0.420 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2009 | 4 | 0.420 |
Why?
|
Fatty Acids | 1 | 2012 | 93 | 0.420 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 2018 | 67 | 0.410 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 90 | 0.400 |
Why?
|
Cardiovascular Diseases | 2 | 2016 | 1059 | 0.400 |
Why?
|
Interleukin-10 | 4 | 2019 | 30 | 0.400 |
Why?
|
Lung Diseases | 2 | 2009 | 44 | 0.390 |
Why?
|
Adiponectin | 1 | 2011 | 117 | 0.390 |
Why?
|
Obesity | 5 | 2019 | 1079 | 0.390 |
Why?
|
Curcumin | 1 | 2010 | 7 | 0.390 |
Why?
|
Chemokine CXCL2 | 2 | 2011 | 9 | 0.390 |
Why?
|
Membrane Glycoproteins | 4 | 2014 | 89 | 0.380 |
Why?
|
RNA-Binding Proteins | 5 | 2015 | 69 | 0.380 |
Why?
|
Nucleosomes | 1 | 2009 | 3 | 0.370 |
Why?
|
Cell Differentiation | 8 | 2017 | 430 | 0.360 |
Why?
|
Cells, Cultured | 5 | 2018 | 779 | 0.360 |
Why?
|
Peroxidase | 1 | 2009 | 32 | 0.350 |
Why?
|
NAD | 3 | 2016 | 24 | 0.350 |
Why?
|
Calgranulin B | 2 | 2019 | 4 | 0.350 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2008 | 12 | 0.340 |
Why?
|
Mice, Inbred BALB C | 10 | 2018 | 156 | 0.330 |
Why?
|
Protein Binding | 5 | 2016 | 182 | 0.330 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 151 | 0.320 |
Why?
|
Transfection | 5 | 2016 | 184 | 0.320 |
Why?
|
Adenosine Triphosphate | 2 | 2019 | 46 | 0.320 |
Why?
|
Blotting, Western | 4 | 2020 | 265 | 0.310 |
Why?
|
Cytokines | 5 | 2017 | 239 | 0.310 |
Why?
|
Interleukin-1 | 5 | 2006 | 35 | 0.310 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2007 | 11 | 0.300 |
Why?
|
Shock, Septic | 2 | 2018 | 28 | 0.300 |
Why?
|
NF-kappa B | 5 | 2017 | 76 | 0.290 |
Why?
|
Metabolome | 2 | 2019 | 32 | 0.290 |
Why?
|
Spleen | 2 | 2014 | 82 | 0.250 |
Why?
|
Immunoprecipitation | 2 | 2016 | 33 | 0.240 |
Why?
|
Transcription Factors | 2 | 2017 | 175 | 0.240 |
Why?
|
Gene Knockdown Techniques | 4 | 2016 | 64 | 0.240 |
Why?
|
Cell Adhesion | 3 | 2017 | 104 | 0.230 |
Why?
|
Receptors, Cell Surface | 2 | 2003 | 71 | 0.230 |
Why?
|
Aging | 3 | 2015 | 857 | 0.230 |
Why?
|
Adaptation, Biological | 1 | 2003 | 6 | 0.230 |
Why?
|
Leukocytes, Mononuclear | 1 | 2003 | 51 | 0.220 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 68 | 0.220 |
Why?
|
Phosphorylation | 4 | 2016 | 205 | 0.220 |
Why?
|
Protein Stability | 3 | 2013 | 25 | 0.220 |
Why?
|
Neutrophils | 4 | 2012 | 102 | 0.210 |
Why?
|
Inflammation Mediators | 3 | 2013 | 101 | 0.210 |
Why?
|
Microcirculation | 2 | 2011 | 61 | 0.200 |
Why?
|
Blood-Brain Barrier | 2 | 2011 | 41 | 0.200 |
Why?
|
Immunomodulation | 3 | 2017 | 29 | 0.200 |
Why?
|
Intercellular Adhesion Molecule-1 | 5 | 2017 | 43 | 0.190 |
Why?
|
STAT3 Transcription Factor | 2 | 2019 | 21 | 0.190 |
Why?
|
Microvessels | 2 | 2017 | 22 | 0.190 |
Why?
|
Cardiomyopathies | 1 | 2020 | 49 | 0.190 |
Why?
|
CpG Islands | 4 | 2016 | 44 | 0.190 |
Why?
|
HSP70 Heat-Shock Proteins | 2 | 2012 | 21 | 0.180 |
Why?
|
Oxidation-Reduction | 3 | 2019 | 251 | 0.180 |
Why?
|
Carbohydrate Metabolism | 1 | 2019 | 12 | 0.170 |
Why?
|
Nucleotides | 1 | 2019 | 16 | 0.170 |
Why?
|
Carnitine | 1 | 2019 | 11 | 0.170 |
Why?
|
Lymphocytes | 1 | 2019 | 52 | 0.170 |
Why?
|
Principal Component Analysis | 1 | 2019 | 60 | 0.170 |
Why?
|
Amino Acids | 1 | 2019 | 35 | 0.170 |
Why?
|
RNA Interference | 2 | 2009 | 71 | 0.170 |
Why?
|
Models, Biological | 4 | 2016 | 356 | 0.170 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2017 | 47 | 0.170 |
Why?
|
Stilbenes | 2 | 2015 | 24 | 0.170 |
Why?
|
Protein Kinases | 3 | 2003 | 26 | 0.170 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 53 | 0.170 |
Why?
|
Oxidative Phosphorylation | 2 | 2015 | 22 | 0.160 |
Why?
|
Lipid Metabolism | 1 | 2019 | 102 | 0.160 |
Why?
|
Myeloid Progenitor Cells | 1 | 2017 | 1 | 0.160 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 69 | 0.160 |
Why?
|
T-Lymphocytes | 3 | 2017 | 114 | 0.150 |
Why?
|
Mitochondrial Proteins | 1 | 2018 | 68 | 0.150 |
Why?
|
Vasculitis | 1 | 2017 | 23 | 0.150 |
Why?
|
Air Pollution | 1 | 2016 | 16 | 0.150 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 144 | 0.150 |
Why?
|
Gene Expression | 2 | 2015 | 324 | 0.150 |
Why?
|
Atherosclerosis | 3 | 2017 | 725 | 0.150 |
Why?
|
E-Selectin | 2 | 2017 | 21 | 0.140 |
Why?
|
Wounds, Nonpenetrating | 2 | 2014 | 88 | 0.140 |
Why?
|
Adoptive Transfer | 2 | 2012 | 16 | 0.140 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 102 | 0.140 |
Why?
|
Antigens, CD34 | 2 | 2012 | 55 | 0.140 |
Why?
|
Immunity, Cellular | 1 | 2015 | 20 | 0.130 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 164 | 0.130 |
Why?
|
Gene Expression Profiling | 3 | 2013 | 323 | 0.130 |
Why?
|
Capillary Permeability | 1 | 2014 | 15 | 0.130 |
Why?
|
Carbazoles | 1 | 2014 | 6 | 0.130 |
Why?
|
Intestine, Small | 1 | 2014 | 34 | 0.130 |
Why?
|
Complement C5a | 1 | 2014 | 2 | 0.120 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 2014 | 2 | 0.120 |
Why?
|
Thrombin | 1 | 2014 | 15 | 0.120 |
Why?
|
Hirudins | 1 | 2014 | 19 | 0.120 |
Why?
|
Aged | 7 | 2017 | 9256 | 0.120 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 64 | 0.120 |
Why?
|
Oxygen Consumption | 1 | 2014 | 138 | 0.120 |
Why?
|
Cholesterol | 1 | 2015 | 231 | 0.120 |
Why?
|
Bone Marrow Cells | 1 | 2014 | 116 | 0.120 |
Why?
|
Cytosol | 1 | 2013 | 25 | 0.120 |
Why?
|
Female | 10 | 2017 | 17679 | 0.120 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2013 | 29 | 0.120 |
Why?
|
Mice, Obese | 3 | 2019 | 20 | 0.110 |
Why?
|
Endothelial Cells | 1 | 2014 | 176 | 0.110 |
Why?
|
Teichoic Acids | 2 | 2003 | 7 | 0.110 |
Why?
|
Immunoblotting | 2 | 2015 | 47 | 0.110 |
Why?
|
Immunosuppression | 3 | 2019 | 80 | 0.110 |
Why?
|
Monocyte-Macrophage Precursor Cells | 1 | 2012 | 3 | 0.110 |
Why?
|
Glucose Transporter Type 1 | 1 | 2012 | 8 | 0.110 |
Why?
|
Receptors, Interleukin-1 | 2 | 2002 | 4 | 0.110 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2012 | 12 | 0.110 |
Why?
|
3' Untranslated Regions | 2 | 2010 | 28 | 0.110 |
Why?
|
Transcriptional Activation | 3 | 2017 | 40 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 22 | 0.110 |
Why?
|
Heat-Shock Proteins | 1 | 2012 | 27 | 0.110 |
Why?
|
Adaptation, Physiological | 1 | 2012 | 44 | 0.110 |
Why?
|
Radioimmunodetection | 1 | 2011 | 3 | 0.110 |
Why?
|
Fluorescence | 1 | 2011 | 22 | 0.110 |
Why?
|
Bone Marrow Transplantation | 1 | 2012 | 65 | 0.100 |
Why?
|
NF-kappa B p50 Subunit | 2 | 2008 | 4 | 0.100 |
Why?
|
Carrier Proteins | 1 | 2012 | 116 | 0.100 |
Why?
|
Microscopy | 1 | 2011 | 26 | 0.100 |
Why?
|
Neutrophil Infiltration | 1 | 2011 | 9 | 0.100 |
Why?
|
Video Recording | 1 | 2011 | 51 | 0.100 |
Why?
|
Middle Aged | 6 | 2017 | 10678 | 0.100 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 21 | 0.100 |
Why?
|
Models, Immunological | 1 | 2011 | 10 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 96 | 0.100 |
Why?
|
Treatment Outcome | 1 | 2018 | 2886 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 236 | 0.100 |
Why?
|
Leukocyte Rolling | 1 | 2010 | 3 | 0.100 |
Why?
|
Microscopy, Video | 1 | 2010 | 7 | 0.100 |
Why?
|
P-Selectin | 1 | 2010 | 11 | 0.100 |
Why?
|
Renilla | 1 | 2010 | 1 | 0.100 |
Why?
|
Aged, 80 and over | 5 | 2016 | 3562 | 0.100 |
Why?
|
Luciferases | 1 | 2010 | 27 | 0.090 |
Why?
|
Drug Tolerance | 1 | 2010 | 17 | 0.090 |
Why?
|
Response Elements | 1 | 2009 | 16 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 202 | 0.090 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 659 | 0.090 |
Why?
|
Lysine | 1 | 2009 | 23 | 0.090 |
Why?
|
Genes, Reporter | 2 | 2016 | 38 | 0.090 |
Why?
|
Trauma Severity Indices | 1 | 2009 | 51 | 0.090 |
Why?
|
Methylation | 1 | 2009 | 5 | 0.090 |
Why?
|
Rats | 3 | 2007 | 1425 | 0.090 |
Why?
|
Antigens, Ly | 2 | 2019 | 6 | 0.090 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 3 | 2003 | 15 | 0.080 |
Why?
|
Genotype | 2 | 2007 | 813 | 0.080 |
Why?
|
Polysaccharides, Bacterial | 1 | 2007 | 10 | 0.080 |
Why?
|
DNA | 1 | 2008 | 207 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2006 | 52 | 0.070 |
Why?
|
Toll-Like Receptors | 2 | 2003 | 21 | 0.070 |
Why?
|
Neuritis | 1 | 2005 | 4 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2007 | 938 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 1556 | 0.070 |
Why?
|
Dendritic Cells | 2 | 2017 | 61 | 0.070 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2005 | 25 | 0.070 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2005 | 38 | 0.070 |
Why?
|
Clonidine | 1 | 2005 | 57 | 0.070 |
Why?
|
Cecum | 2 | 2015 | 9 | 0.060 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 35 | 0.060 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2003 | 6 | 0.060 |
Why?
|
Pain | 1 | 2005 | 247 | 0.060 |
Why?
|
Leukocyte Count | 2 | 2017 | 54 | 0.060 |
Why?
|
Gene Deletion | 2 | 2017 | 64 | 0.050 |
Why?
|
Dealkylation | 1 | 2002 | 2 | 0.050 |
Why?
|
Blotting, Northern | 1 | 2002 | 23 | 0.050 |
Why?
|
Half-Life | 1 | 2002 | 22 | 0.050 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2002 | 17 | 0.050 |
Why?
|
Chromatin | 1 | 2002 | 18 | 0.050 |
Why?
|
Binding Sites | 2 | 2016 | 112 | 0.050 |
Why?
|
Drosophila Proteins | 1 | 2002 | 44 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 147 | 0.050 |
Why?
|
Genome, Human | 2 | 2014 | 148 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2015 | 515 | 0.050 |
Why?
|
Echocardiography | 1 | 2020 | 142 | 0.050 |
Why?
|
Myocytes, Cardiac | 1 | 2020 | 102 | 0.050 |
Why?
|
Chemokines, CXC | 2 | 2011 | 9 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2019 | 58 | 0.040 |
Why?
|
Antibodies | 1 | 2018 | 50 | 0.040 |
Why?
|
Adult | 1 | 2011 | 8243 | 0.040 |
Why?
|
Protein-Serine-Threonine Kinases | 1 | 2018 | 42 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2003 | 578 | 0.040 |
Why?
|
Cell Lineage | 1 | 2017 | 68 | 0.040 |
Why?
|
Gene Targeting | 1 | 2017 | 16 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2017 | 49 | 0.040 |
Why?
|
Nitrogen Oxides | 1 | 2016 | 5 | 0.040 |
Why?
|
Air Pollutants | 1 | 2016 | 19 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2017 | 169 | 0.040 |
Why?
|
Particulate Matter | 1 | 2016 | 29 | 0.040 |
Why?
|
Retinoblastoma Protein | 1 | 2016 | 10 | 0.040 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2016 | 17 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2017 | 113 | 0.040 |
Why?
|
Antigens, CD | 1 | 2016 | 101 | 0.040 |
Why?
|
Antigens, Surface | 1 | 2015 | 19 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 1236 | 0.030 |
Why?
|
Gene Dosage | 1 | 2015 | 32 | 0.030 |
Why?
|
Ribosomes | 1 | 2015 | 10 | 0.030 |
Why?
|
Ribonucleotide Reductases | 1 | 2015 | 6 | 0.030 |
Why?
|
Endopeptidases | 1 | 2015 | 26 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 44 | 0.030 |
Why?
|
African Continental Ancestry Group | 1 | 2016 | 376 | 0.030 |
Why?
|
Haplotypes | 2 | 2007 | 255 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2017 | 567 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 169 | 0.030 |
Why?
|
Autophagy | 1 | 2015 | 53 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 65 | 0.030 |
Why?
|
Survival Rate | 1 | 2016 | 775 | 0.030 |
Why?
|
Transcription Initiation Site | 1 | 2013 | 10 | 0.030 |
Why?
|
Feedback, Physiological | 1 | 2013 | 9 | 0.030 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2013 | 7 | 0.030 |
Why?
|
Glutathione Transferase | 1 | 2013 | 18 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2013 | 23 | 0.030 |
Why?
|
Protein Transport | 1 | 2013 | 64 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2013 | 39 | 0.030 |
Why?
|
Phagocytosis | 1 | 2012 | 9 | 0.030 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2012 | 3 | 0.030 |
Why?
|
Arginase | 1 | 2012 | 8 | 0.030 |
Why?
|
Weight Loss | 1 | 2015 | 411 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2002 | 155 | 0.030 |
Why?
|
Peritonitis | 1 | 2011 | 10 | 0.030 |
Why?
|
Cholesterol, Dietary | 1 | 2012 | 37 | 0.030 |
Why?
|
Peritoneum | 1 | 2011 | 24 | 0.030 |
Why?
|
Macrophages, Peritoneal | 1 | 2011 | 19 | 0.030 |
Why?
|
European Continental Ancestry Group | 1 | 2016 | 1203 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 89 | 0.030 |
Why?
|
Receptors, Interleukin-8B | 1 | 2011 | 4 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2012 | 109 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 615 | 0.020 |
Why?
|
Lipids | 1 | 2012 | 215 | 0.020 |
Why?
|
Cohort Studies | 1 | 2014 | 1673 | 0.020 |
Why?
|
Hispanic Americans | 1 | 2016 | 935 | 0.020 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2009 | 16 | 0.020 |
Why?
|
Blood Glucose | 1 | 2012 | 485 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2012 | 494 | 0.020 |
Why?
|
United States | 1 | 2016 | 3588 | 0.020 |
Why?
|
Genetic Techniques | 1 | 2007 | 7 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2012 | 486 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2007 | 22 | 0.020 |
Why?
|
Necrosis | 1 | 2007 | 49 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2007 | 222 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 161 | 0.020 |
Why?
|
Alleles | 1 | 2007 | 273 | 0.020 |
Why?
|
Time Factors | 1 | 2011 | 1874 | 0.020 |
Why?
|
Chemokines, CC | 1 | 2006 | 5 | 0.020 |
Why?
|
Neutrophil Activation | 1 | 2006 | 5 | 0.020 |
Why?
|
Zymosan | 1 | 2005 | 5 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2005 | 73 | 0.020 |
Why?
|
Protein Precursors | 1 | 2005 | 18 | 0.020 |
Why?
|
Antibody Formation | 1 | 2005 | 38 | 0.020 |
Why?
|
Hyperalgesia | 1 | 2005 | 74 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 624 | 0.020 |
Why?
|
Base Sequence | 1 | 2003 | 241 | 0.010 |
Why?
|
Gene Frequency | 1 | 2003 | 272 | 0.010 |
Why?
|
Sialoglycoproteins | 1 | 2002 | 7 | 0.010 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 9 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2003 | 340 | 0.010 |
Why?
|
Enzyme Stability | 1 | 2002 | 5 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2002 | 38 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2002 | 71 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2002 | 32 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2002 | 120 | 0.010 |
Why?
|
Isoenzymes | 1 | 2002 | 59 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 88 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2002 | 480 | 0.010 |
Why?
|
Risk Factors | 1 | 2003 | 3520 | 0.010 |
Why?
|